Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
J Ethnopharmacol ; 194: 137-145, 2016 Dec 24.
Article in English | MEDLINE | ID: mdl-27596328

ABSTRACT

ETHNOPHARMACOLOGICAL RELEVANCE: Passiflora caerulea L. (Passifloraceae) is a medicinal plant commonly used in traditional medicine in South America for different pathologies associated with the gastrointestinal tract. AIM OF THE STUDY: In the present study, the activity of the ethanolic extract of P. caerulea on an experimental colitis model related to inflammatory bowel disease has been investigated. MATERIALS AND METHODS: Colitis was induced by intracolonic instillation of a 2mL of 4% (v/v) acetic acid solution. Macroscopic scoring, myeloperoxidase activity and thiobarbituric acid reactive substances levels were evaluated on isolated colon mucosae. The histopathological studies of colon mucosae were performed by hematoxylin and eosin and Alcian blue staining. Diarrhoea was induced by the administration of castor oil (0.3mL/mouse). The first watery defecation time, the total amount of solid, semi-solid and watery stools and the amount of watery stools were determined. The effect of the extract on a cumulative concentration-response curve of acetylcholine and CaCl2 on isolated rat jejunum was also evaluated. The phytochemical analysis was performed. RESULTS: The extract (250mg/kg, p.o.) induced a significant reduction in the weight/length ratio, the macroscopic lesion score, TBARS levels and the microscopic tissue damage when compared with the acetic acid-treated group of animals. P. caerulea (125mg/kg, p.o.) decreased significantly the amount of watery stools in the castor oil-induced-diarrhoea model. Moreover, the P. caerulea extract antagonized the jejunum contractions induced by Ach (Emax for 0.3mg/mL: 76.25%; Emax for 1mg/mL: 63.47%; Emax for 3mg/mL: 42.01%) and CaCl2 (Emax for 0.3mg/mL: 75.69%; Emax for1 mg/mL: 56.1%; Emax for 3mg/mL: 53.4%). Isoorientin, vitexin, isovitexin, and vicenin-2 were identified in the extract. CONCLUSION: P. caerulea showed anti-inflammatory, anti-diarrhoeal and spasmolityc activities on preclinical models.


Subject(s)
Colitis/drug therapy , Disease Models, Animal , Passiflora/chemistry , Plant Extracts/therapeutic use , Animals , Female , Mice
2.
Phytother Res ; 29(1): 59-66, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25256913

ABSTRACT

Urera aurantiaca Wedd. (Urticaceae) is a medicinal plant commonly used in traditional medicine to relieve pain in inflammatory processes. In the present study, the in vivo anti-inflammatory and antinociceptive effects of U. aurantiaca methanolic extract and its possible mechanisms of action were investigated. The extract showed anti-inflammatory activity in the ear edema in mice test (34.3% inhibition), myeloperoxidase (MPO) activity was markedly reduced in animals administered with the extract: within 49.6% and 68.5%. In the histological analysis, intense dermal edema and intense cellular infiltration of inflammatory cells were markedly reduced in the ear tissue of the animals treated with the extract. In the carrageenan-induced hind paw edema in rats assay the extract provoked a significant inhibition of the inflammation (45.5%, 5 h after the treatment) and the MPO activity was markedly reduced (maximum inhibition 71.7%), The extract also exhibited significant and dose-dependent inhibitory effect on the increased vascular permeability induced by acetic acid. The extract presented antioxidant activity in both 2,2-diphenyl-1-picrylhydrazyl and 2,2'-azinobis 3-ethylbenzothiazoline 6-sulfonic acid tests and its total phenol content was 35.4 ± 0.06 mg GAE/g of extract. Also, the extract produced significant inhibition on nociception induced by acetic acid (ED50 : 8.7 mg/kg, i.p.) administered intraperitoneally and orally. Naloxone significantly prevented this activity.


Subject(s)
Analgesics/pharmacology , Anti-Inflammatory Agents/pharmacology , Plant Extracts/pharmacology , Urticaceae/chemistry , Acetic Acid/adverse effects , Animals , Carrageenan/adverse effects , Edema/drug therapy , Female , Free Radical Scavengers/chemistry , Inflammation/drug therapy , Male , Mice , Pain/drug therapy , Peroxidase/metabolism , Phytotherapy , Plant Components, Aerial/chemistry , Plants, Medicinal/chemistry , Rats , Rats, Sprague-Dawley
3.
Phytother Res ; 25(10): 1466-71, 2011 Oct.
Article in English | MEDLINE | ID: mdl-21953709

ABSTRACT

Tilia species have been used in Europe and in America to treat anxiety and also for the treatment of colds, influenza, bronchitis, fever and inflammation. Tilia × viridis is a Tilia species distributed widely in Buenos Aires, Argentina. The flavonoids present in Tilia species have antioxidant properties, acting as reactive oxygen species (ROS) scavengers, principally on hydrogen peroxide (H(2)O(2)) and the superoxide anion (O(2)(·-)), which are involved in many diseases, including cancer. The aim of this study was to determine the phytochemical pattern of the ethanol extract of Tilia × viridis, principally the flavonoid content, and to evaluate the antiproliferative effects on both normal and tumoral cells, and the antioxidant activity in relation to H(2)O(2) modulation. The extract was found to present a selective antiproliferative activity on a lymphoma cell line and this was related to free radical scavenging activity. In addition, one of its main compounds, rutin, showed antioxidant effects related to peroxidase activity. T. × viridis may therefore be a source of antioxidant compounds that contribute to a selective antiproliferative action on tumoral cells, acting by modulation of H(2)O(2) levels.


Subject(s)
Antineoplastic Agents, Phytogenic/therapeutic use , Antioxidants/therapeutic use , Flavonoids/therapeutic use , Lymphoma/drug therapy , Phytotherapy , Plant Extracts/therapeutic use , Tilia , Animals , Antineoplastic Agents, Phytogenic/pharmacology , Antioxidants/pharmacology , Cell Line, Tumor , Cell Proliferation/drug effects , Chromatography, High Pressure Liquid , Flavonoids/pharmacology , Flowers , Hydrogen Peroxide/metabolism , Lymphoma/metabolism , Male , Mice , Peroxidase/metabolism , Plant Extracts/chemistry , Plant Extracts/pharmacology , Reactive Oxygen Species/metabolism , Rutin/pharmacology , Rutin/therapeutic use , Superoxides/metabolism , Tilia/chemistry
4.
J Ethnopharmacol ; 134(3): 733-8, 2011 Apr 12.
Article in English | MEDLINE | ID: mdl-21277970

ABSTRACT

ETHNOPHARMACOLOGICAL RELEVANCE: Urtica circularis (Hicken) Sorarú is a medicinal plant commonly used in traditional medicine to relieve pain in inflammatory processes. AIM OF THE STUDY: In the present study, the in vivo antinociceptive effect of Urtica circularis ethanolic extract and its isolated compounds has been investigated. MATERIALS AND METHODS: Antinociceptive activity was evaluated through writhing, formalin and hot plate tests in mice. The phytochemical analysis was performed. RESULTS: The extract produced significant inhibition on nociception induced by acetic acid (ED50: 72.2mg/kg, i.p.) and formalin (ED50: 15.8 mg/kg, i.p.) administered intraperitoneally and also orally. Atropine diminished the activity of the extract in the acetic acid test. In this model, at dose of 10mg/kg i.p., vitexin was the most active of the isolated compounds (inhibition of 91%), and chlorogenic acid, caffeic acid and vicenin-2 (6,8-di-C-glucosyl apigenin) produced an inhibition of 72%, 41% and 41%, respectively, whereas apigenin did not show any activity. CONCLUSIONS: These results suggest that Urtica circularis extract produced antinociception possibly related to the presence of vitexin, chlorogenic, caffeic acid and vicenin-2. The activation of cholinergic systems seems to be involved in the mechanism of antinociception of the extract.


Subject(s)
Analgesics/pharmacology , Plant Extracts/pharmacology , Urticaceae/chemistry , Animals , Chromatography, High Pressure Liquid , Drug Evaluation, Preclinical , Ethanol/chemistry , Mice , Plant Extracts/chemistry , Stomach/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...